+1 (704) 266-3234

Global Hepatitis A Vaccine Market Insights, Forecast To 2025

Published on: Apr 2019 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 111

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Two types of HAV vaccines are currently available internationally:

1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.
Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
The global Hepatitis A Vaccine market is valued at 650 million US$ in 2018 and will reach 760 million US$ by the end of 2025, growing at a CAGR of 2.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hepatitis A Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Hepatitis A Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hepatitis A Vaccine in these regions.
This research report categorizes the global Hepatitis A Vaccine market by top players/brands, region, type and end user. This report also studies the global Hepatitis A Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
Kaketsuken
IMBCA
ChangSheng
Convac

Market size by Product
Inactivated Vaccine
Live Attenuated Vaccine
Market size by End User
Government Institution
Private Sector
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Hepatitis A Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hepatitis A Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hepatitis A Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hepatitis A Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Hepatitis A Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hepatitis A Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Hepatitis A Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Hepatitis A Vaccine Market Size Growth Rate by Product
1.4.2 Inactivated Vaccine
1.4.3 Live Attenuated Vaccine
1.5 Market by End User
1.5.1 Global Hepatitis A Vaccine Market Size Growth Rate by End User
1.5.2 Government Institution
1.5.3 Private Sector
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Hepatitis A Vaccine Market Size
2.1.1 Global Hepatitis A Vaccine Revenue 2014-2025
2.1.2 Global Hepatitis A Vaccine Sales 2014-2025
2.2 Hepatitis A Vaccine Growth Rate by Regions
2.2.1 Global Hepatitis A Vaccine Sales by Regions
2.2.2 Global Hepatitis A Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Hepatitis A Vaccine Sales by Manufacturers
3.1.1 Hepatitis A Vaccine Sales by Manufacturers
3.1.2 Hepatitis A Vaccine Sales Market Share by Manufacturers
3.1.3 Global Hepatitis A Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Hepatitis A Vaccine Revenue by Manufacturers
3.2.1 Hepatitis A Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Hepatitis A Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Hepatitis A Vaccine Price by Manufacturers
3.4 Hepatitis A Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hepatitis A Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Hepatitis A Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Hepatitis A Vaccine Sales by Product
4.2 Global Hepatitis A Vaccine Revenue by Product
4.3 Hepatitis A Vaccine Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Hepatitis A Vaccine Breakdown Data by End User

6 North America
6.1 North America Hepatitis A Vaccine by Countries
6.1.1 North America Hepatitis A Vaccine Sales by Countries
6.1.2 North America Hepatitis A Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Hepatitis A Vaccine by Product
6.3 North America Hepatitis A Vaccine by End User

7 Europe
7.1 Europe Hepatitis A Vaccine by Countries
7.1.1 Europe Hepatitis A Vaccine Sales by Countries
7.1.2 Europe Hepatitis A Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hepatitis A Vaccine by Product
7.3 Europe Hepatitis A Vaccine by End User

8 Asia Pacific
8.1 Asia Pacific Hepatitis A Vaccine by Countries
8.1.1 Asia Pacific Hepatitis A Vaccine Sales by Countries
8.1.2 Asia Pacific Hepatitis A Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Hepatitis A Vaccine by Product
8.3 Asia Pacific Hepatitis A Vaccine by End User

9 Central & South America
9.1 Central & South America Hepatitis A Vaccine by Countries
9.1.1 Central & South America Hepatitis A Vaccine Sales by Countries
9.1.2 Central & South America Hepatitis A Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Hepatitis A Vaccine by Product
9.3 Central & South America Hepatitis A Vaccine by End User

10 Middle East and Africa
10.1 Middle East and Africa Hepatitis A Vaccine by Countries
10.1.1 Middle East and Africa Hepatitis A Vaccine Sales by Countries
10.1.2 Middle East and Africa Hepatitis A Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Hepatitis A Vaccine by Product
10.3 Middle East and Africa Hepatitis A Vaccine by End User

11 Company Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 Company Business Overview
11.1.3 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GSK Hepatitis A Vaccine Products Offered
11.1.5 GSK Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Business Overview
11.2.3 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merck Hepatitis A Vaccine Products Offered
11.2.5 Merck Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Business Overview
11.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Sanofi Hepatitis A Vaccine Products Offered
11.3.5 Sanofi Recent Development
11.4 Sinovac
11.4.1 Sinovac Company Details
11.4.2 Company Business Overview
11.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sinovac Hepatitis A Vaccine Products Offered
11.4.5 Sinovac Recent Development
11.5 Zhejiang Pukang
11.5.1 Zhejiang Pukang Company Details
11.5.2 Company Business Overview
11.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Zhejiang Pukang Hepatitis A Vaccine Products Offered
11.5.5 Zhejiang Pukang Recent Development
11.6 Changchun Institute of Biological
11.6.1 Changchun Institute of Biological Company Details
11.6.2 Company Business Overview
11.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Changchun Institute of Biological Hepatitis A Vaccine Products Offered
11.6.5 Changchun Institute of Biological Recent Development
11.7 Kaketsuken
11.7.1 Kaketsuken Company Details
11.7.2 Company Business Overview
11.7.3 Kaketsuken Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Kaketsuken Hepatitis A Vaccine Products Offered
11.7.5 Kaketsuken Recent Development
11.8 IMBCA
11.8.1 IMBCA Company Details
11.8.2 Company Business Overview
11.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 IMBCA Hepatitis A Vaccine Products Offered
11.8.5 IMBCA Recent Development
11.9 ChangSheng
11.9.1 ChangSheng Company Details
11.9.2 Company Business Overview
11.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 ChangSheng Hepatitis A Vaccine Products Offered
11.9.5 ChangSheng Recent Development
11.10 Convac
11.10.1 Convac Company Details
11.10.2 Company Business Overview
11.10.3 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Convac Hepatitis A Vaccine Products Offered
11.10.5 Convac Recent Development

12 Future Forecast
12.1 Hepatitis A Vaccine Market Forecast by Regions
12.1.1 Global Hepatitis A Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Hepatitis A Vaccine Revenue Forecast by Regions 2019-2025
12.2 Hepatitis A Vaccine Market Forecast by Product
12.2.1 Global Hepatitis A Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Hepatitis A Vaccine Revenue Forecast by Product 2019-2025
12.3 Hepatitis A Vaccine Market Forecast by End User
12.4 North America Hepatitis A Vaccine Forecast
12.5 Europe Hepatitis A Vaccine Forecast
12.6 Asia Pacific Hepatitis A Vaccine Forecast
12.7 Central & South America Hepatitis A Vaccine Forecast
12.8 Middle East and Africa Hepatitis A Vaccine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hepatitis A Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Hepatitis A Vaccine Product Picture
Table Hepatitis A Vaccine Market Segments
Table Key Manufacturers Hepatitis A Vaccine Covered
Table Global Hepatitis A Vaccine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Hepatitis A Vaccine Sales Market Share by Product 2014-2025
Figure Inactivated Vaccine Product Picture
Table Major Manufacturers of Inactivated Vaccine
Figure Live Attenuated Vaccine Product Picture
Table Major Manufacturers of Live Attenuated Vaccine
Table Global Hepatitis A Vaccine Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Government Institution
Figure Private Sector
Figure Other
Figure Hepatitis A Vaccine Report Years Considered
Figure Global Hepatitis A Vaccine Market Size 2014-2025 (Million US$)
Figure Global Hepatitis A Vaccine Sales 2014-2025 (K Units)
Table Global Hepatitis A Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Hepatitis A Vaccine Sales by Regions 2014-2019 (K Units)
Table Global Hepatitis A Vaccine Sales Market Share by Regions 2014-2019
Figure Global Hepatitis A Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Hepatitis A Vaccine Sales Market Share by Regions
Table Global Hepatitis A Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Hepatitis A Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Hepatitis A Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Hepatitis A Vaccine Revenue Market Share by Regions
Table Global Hepatitis A Vaccine Sales by Manufacturers (2014-2019) (K Units)
Table Global Hepatitis A Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Hepatitis A Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Hepatitis A Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Hepatitis A Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Hepatitis A Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Hepatitis A Vaccine Price (2014-2019) (USD/Unit)
Table Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Hepatitis A Vaccine Product Type
Table Date of International Manufacturers Enter into Hepatitis A Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Hepatitis A Vaccine Sales by Product (2014-2019) (K Units)
Table Global Hepatitis A Vaccine Sales Share by Product (2014-2019)
Figure Global Hepatitis A Vaccine Sales Market Share by Product (2014-2019)
Figure Global Hepatitis A Vaccine Sales Market Share by Product in 2018
Table Global Hepatitis A Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Hepatitis A Vaccine Revenue Share by Product (2014-2019)
Figure Global Hepatitis A Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Hepatitis A Vaccine Revenue Market Share by Product in 2018
Table Hepatitis A Vaccine Price by Product 2014-2019 (USD/Unit)
Table Global Hepatitis A Vaccine Sales by End User (2014-2019) (K Units)
Table Global Hepatitis A Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Hepatitis A Vaccine Market Share by End User (2014-2019)
Figure Global Sales Hepatitis A Vaccine Market Share by End User in 2018
Figure North America Hepatitis A Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure North America Hepatitis A Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Hepatitis A Vaccine Sales by Countries (2014-2019) (K Units)
Table North America Hepatitis A Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Hepatitis A Vaccine Sales Market Share by Countries
Table North America Hepatitis A Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Hepatitis A Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Hepatitis A Vaccine Revenue Market Share by Countries
Figure United States Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure United States Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Hepatitis A Vaccine Sales by Product (2014-2019) (K Units)
Table North America Hepatitis A Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Hepatitis A Vaccine Market Share by Product
Table North America Hepatitis A Vaccine Sales by End User (2014-2019) (K Units)
Table North America Hepatitis A Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Hepatitis A Vaccine Market Share by End User
Figure Europe Hepatitis A Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Hepatitis A Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Hepatitis A Vaccine Sales by Countries (2014-2019) (K Units)
Table Europe Hepatitis A Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Hepatitis A Vaccine Sales Market Share by Countries
Table Europe Hepatitis A Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Hepatitis A Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Hepatitis A Vaccine Revenue Market Share by Countries
Figure Germany Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Germany Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure France Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure UK Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Hepatitis A Vaccine Sales by Product (2014-2019) (K Units)
Table Europe Hepatitis A Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Hepatitis A Vaccine Market Share by Product
Table Europe Hepatitis A Vaccine Sales by End User (2014-2019) (K Units)
Table Europe Hepatitis A Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Hepatitis A Vaccine Market Share by End User
Figure Asia Pacific Hepatitis A Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Hepatitis A Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Hepatitis A Vaccine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Hepatitis A Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Hepatitis A Vaccine Sales Market Share by Countries
Table Asia Pacific Hepatitis A Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Hepatitis A Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Hepatitis A Vaccine Revenue Market Share by Countries
Figure China Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure China Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure India Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Hepatitis A Vaccine Sales by Product (2014-2019) (K Units)
Table Asia Pacific Hepatitis A Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Hepatitis A Vaccine Market Share by Product
Table Asia Pacific Hepatitis A Vaccine Sales by End User (2014-2019) (K Units)
Table Asia Pacific Hepatitis A Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Hepatitis A Vaccine Market Share by End User
Figure Central & South America Hepatitis A Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Hepatitis A Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Hepatitis A Vaccine Sales by Countries (2014-2019) (K Units)
Table Central & South America Hepatitis A Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Hepatitis A Vaccine Sales Market Share by Countries
Table Central & South America Hepatitis A Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Hepatitis A Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Hepatitis A Vaccine Revenue Market Share by Countries
Figure Brazil Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Hepatitis A Vaccine Sales by Product (2014-2019) (K Units)
Table Central & South America Hepatitis A Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Hepatitis A Vaccine Market Share by Product
Table Central & South America Hepatitis A Vaccine Sales by End User (2014-2019) (K Units)
Table Central & South America Hepatitis A Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Hepatitis A Vaccine Market Share by End User
Figure Middle East and Africa Hepatitis A Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Hepatitis A Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Hepatitis A Vaccine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Hepatitis A Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Hepatitis A Vaccine Sales Market Share by Countries
Table Middle East and Africa Hepatitis A Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Countries
Figure GCC Countries Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Hepatitis A Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Hepatitis A Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Hepatitis A Vaccine Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Hepatitis A Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Hepatitis A Vaccine Market Share by Product
Table Middle East and Africa Hepatitis A Vaccine Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Hepatitis A Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Hepatitis A Vaccine Market Share by End User
Table GSK Company Details
Table GSK Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Recent Development

Table Merck Company Details
Table Merck Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development

Table Sanofi Company Details
Table Sanofi Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development

Table Sinovac Company Details
Table Sinovac Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sinovac Recent Development

Table Zhejiang Pukang Company Details
Table Zhejiang Pukang Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Zhejiang Pukang Recent Development

Table Changchun Institute of Biological Company Details
Table Changchun Institute of Biological Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Changchun Institute of Biological Recent Development

Table Kaketsuken Company Details
Table Kaketsuken Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kaketsuken Recent Development

Table IMBCA Company Details
Table IMBCA Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table IMBCA Recent Development

Table ChangSheng Company Details
Table ChangSheng Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table ChangSheng Recent Development

Table Convac Company Details
Table Convac Hepatitis A Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Convac Recent Development

Table Global Hepatitis A Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Table Global Hepatitis A Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Hepatitis A Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Hepatitis A Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Hepatitis A Vaccine Sales Forecast by Product 2019-2025 (K Units)
Table Global Hepatitis A Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Hepatitis A Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Hepatitis A Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Hepatitis A Vaccine Sales Forecast by End User 2019-2025 (K Units)
Table Global Hepatitis A Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Hepatitis A Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Hepatitis A Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Hepatitis A Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Hepatitis A Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Hepatitis A Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Hepatitis A Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Hepatitis A Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Hepatitis A Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Hepatitis A Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Hepatitis A Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Hepatitis A Vaccine Value Chain
Table Hepatitis A Vaccine Customers List
Table Hepatitis A Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.